![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
C12N 15/13 | |||
C12N 15/63 | |||
A61P 35/00 | |||
C07K 16/32 | |||
A61K 39/00 | |||
C07K 16/30 |
(11) | Number of the document | 2540745 |
(13) | Kind of document | T |
(96) | European patent application number | 10846324.1 |
Date of filing the European patent application | 2010-04-16 | |
(97) | Date of publication of the European application | 2013-01-02 |
(45) | Date of publication and mention of the grant of the patent | 2015-09-30 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2010/000511 |
Date | 2010-04-16 |
(87) | Number | WO 2011/103700 |
Date | 2011-09-01 |
(30) | Number | Date | Country code |
201010125241 | 2010-02-25 | CN |
(72) |
LI, Chuan, CN
TONG, Xin, CN
KAN, Ying, CN
|
(73) |
Shanghai Biomabs Pharmaceuticals Co., Ltd,
No. 301, Libing Road, Pudong District Shanghai 201203,
CN
|
(54) | FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |
FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |